{"retracted":false,"update":{"timestamp":1446422400000,"doi":"10.1007/s00259-015-3238-8","type":"correction"},"doi":"10.1007/s00259-015-3124-4","journal":"European Journal of Nuclear Medicine and Molecular Imaging","publisher":"Springer Nature","title":"Erratum to: Difficulties in deciding whether to ablate patients with putatively “low–intermediate-risk” differentiated thyroid carcinoma: do guidelines mainly apply in the centres that produce them? Results of a retrospective, two-centre quality assurance study"}
